Advertisement

Topics

Percutaneous Valve Technologies, Inc. (PVT) Company Profile

13:15 EDT 20th March 2019 | BioPortfolio

Nil


News Articles [667 Associated News Articles listed on BioPortfolio]

Abbott Advances Transcath Mitral Valve Efforts With Cephea Acquisition

Abbott has exercised an option to buy Cephea Valve Technologies, developer of a minimally-invasive replacement heart valve, for an undisclosed...   

Abbott to boost heart valve therapy portfolio with acquisition of Cephea Valve Technologies

As mergers and acquisitions pick up again for the New Year, Abbott has revealed plans to buy medical device firm Cephea Valve Technologies, acting on an option it secured in 2015 with the acquisition ...

Abbott to Acquire Mitral Valve Device Maker Cephea Valve Technologies

ABBOTT PARK, Ill., Jan. 16, 2019 /PRNewswire/ — Abbott (NYSE: ABT) announced today that it has exercised its option to purchase Cephea Valve Technologies, Inc., a privately h...

Abbott to acquire Cephea Valve Technologies, Inc.

Abbott (NYSE: ABT) announced today that it has exercised its option to purchase Cephea Valve Technologies, Inc., a privately held medical device company developing a less-invasive heart valve replacem...

Abbott exercises purchase option for Cephea Valve Technologies

Abbott has exercised an option from 2015 to acquire Cephea Valve Technologies, which is developing a mitral valve replacement -More- 

Abbott All In With Cephea Valve Technologies Acquisition

Abbott has exercised an option to buy Cephea Valve Technologies, developer of a minimally-invasive replacement heart valve, for an undisclosed...   

MitraClip does not significantly improve outcomes in secondary mitral regurgitation: the MITRA-FR trial

1. Among patients with heart failure with reduced ejection fraction (HFrEF) and severe secondary mitral regurgitation on medical therapy, percutaneous mitral valve repair did not significantly reduce ...

CT analysis before percutaneous PVI aids heart disease patients

Performing CT analysis prior to percutaneous pulmonary valve implantation (PPVI) in patients with congenital heart disease (CHD) may assist physicians in detecting those who are most at-risk for co...

PubMed Articles [1611 Associated PubMed Articles listed on BioPortfolio]

SAPIEN valve for percutaneous transcatheter pulmonary valve replacement without "pre-stenting": A multi-institutional experience.

To describe a multicenter experience of percutaneous transcatheter pulmonary valve replacement (TPVR) using the Edwards SAPIEN S3 valve without the use of a prior stent ("pre-stenting").

Initial results from the off-label use of the SAPIEN S3 valve for percutaneous transcatheter pulmonary valve replacement: A multi-institutional experience.

To describe a multi-center experience of percutaneous transcatheter pulmonary valve replacement (TPVR) using the Edwards Sapien S3 Valve.

Medium-Term Results of Percutaneous Pulmonary Valve Implantation using The Venus P-valve™: international experience.

To assess international procedural and short to medium-term experience with the new percutaneous Venus P-Valve™.

Previous TAVR in patients undergoing percutaneous edge-to-edge mitral valve repair (PMVR) affects improvement of MR.

Patients after transcatheter aortic valve replacement (TAVR) and persistent severe mitral regurgitation (MR) are increasingly treated with percutaneous edge-to-edge mitral valve repair (PMVR). The imp...

Percutaneous melody valve implantation in a native tricuspid valve following failed surgical repair.

Transcatheter valve-in-valve and valve-in-ring implantation has become a common approach to treating patients with failed bioprosthetic tricuspid valves as well as failed surgical repairs of the tricu...

Clinical Trials [2336 Associated Clinical Trials listed on BioPortfolio]

Feasibility Study of a Percutaneous Mitral Valve Repair System.

Prospective, multi-center, Phase I study of the Evalve Cardiovascular Valve Repair System (CVRS) in the treatment of mitral valve regurgitation. Patients will undergo 30-day, 6 month, 12 ...

Multi-center Trial of Percutaneous Pulmonary Valve Implantation With Venus-p

Venus-P Valve (Venus Medtech, Shanghai, China) is the first self-expandable interventional Pulmonary Valve, which is composed of a Nitinol multilevel support frame with a tri-leaflet porci...

Percutaneous Treatment of Tricuspid Valve Regurgitation With the TriCinch System™

The TriCinch System™ is intended for percutaneous treatment of tricuspid regurgitation. It is a percutaneous catheter-based device designed for tricuspid valve repair in order to decrea...

Balloon Aortic Valvuloplasty During Surgical Aortic Valve Replacement

Prospective, two academic center, non-randomized pilot, acute in-patient study correlating pre-operative imaging studies, intra-operative measurements and intra-operative balloon aortic va...

The Italian Society of Invasive Cardiology Registry on Percutaneous Aortic Valve

The Italian Society of Invasive Cardiology Registry on Percutaneous Aortic Valve is a prospective Italian registry including several centers performing TAVI, collecting baseline, procedura...

Companies [1372 Associated Companies listed on BioPortfolio]

Percutaneous Valve Technologies, Inc. (PVT)

Nil

Colibri Heart Valve, LLC

Colibri Heart Valve, LLC is a privately held medical device company committed to the research and development of novel heart valve technologies, including the Company’s dry, ...

Thubrikar Aortic Valve, Inc.

Thubrikar Aortic Valve, Inc., founded in October 2010, is a privately held medical device company headquartered in Norristown, PA. The Company has developed a low-profile, bovine ...

Transcatheter Technologies GmbH

Transcatheter Technologies GmbH is a privately held medical device company, founded in January 2009, and headquartered in Regensburg, Germany. The Trinity transapical aortic valve system's valve p...

Mitralign, Inc.

Mitralign is a cardiac device company founded by the Accelerated Technologies (ATI) medical device incubator. The company has developed and is currently testing an innovative, cat...

More Information about "Percutaneous Valve Technologies, Inc. (PVT)" on BioPortfolio

We have published hundreds of Percutaneous Valve Technologies, Inc. (PVT) news stories on BioPortfolio along with dozens of Percutaneous Valve Technologies, Inc. (PVT) Clinical Trials and PubMed Articles about Percutaneous Valve Technologies, Inc. (PVT) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Percutaneous Valve Technologies, Inc. (PVT) Companies in our database. You can also find out about relevant Percutaneous Valve Technologies, Inc. (PVT) Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record